Assets, Current of Innovation1 Biotech Inc. from 31 Aug 2017 to 29 Feb 2024

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
Innovation1 Biotech Inc. quarterly Assets, Current in USD history and change rate from 31 Aug 2017 to 29 Feb 2024.
  • Innovation1 Biotech Inc. Assets, Current for the quarter ending 29 Feb 2024 was $118,777, a 16% decline year-over-year.
Source SEC data
View on sec.gov
Assets, Current, Quarterly (USD)
Assets, Current, YoY Quarterly Change (%)

Innovation1 Biotech Inc. Quarterly Assets, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $118,777 -$23,218 -16% 29 Feb 2024 10-Q 06 May 2025 2024 Q2
Q4 2023 $17,069 -$103,672 -86% 30 Nov 2023 10-Q 27 Jan 2025 2023 Q1
Q3 2023 $72,744 -$214,212 -75% 31 Aug 2023 10-Q 06 May 2025 2024 Q2
Q2 2023 $162,948 -$657,458 -80% 31 May 2023 10-Q 13 Sep 2023 2023 Q3
Q1 2023 $141,995 -$1,378,360 -91% 28 Feb 2023 10-Q 30 May 2023 2023 Q2
Q4 2022 $120,741 -$2,828,421 -96% 30 Nov 2022 10-Q 17 Jan 2023 2023 Q1
Q3 2022 $286,956 +$118,480 +70% 31 Aug 2022 10-K 17 Jan 2024 2023 FY
Q2 2022 $820,406 +$768,854 +1491% 31 May 2022 10-Q 14 Jul 2022 2022 Q3
Q1 2022 $1,520,355 +$1,391,530 +1080% 28 Feb 2022 10-Q 15 Apr 2022 2022 Q2
Q4 2021 $2,949,162 +$2,767,050 +1519% 30 Nov 2021 10-Q/A 01 Feb 2022 2022 Q1
Q3 2021 $168,476 -$33,652 -17% 31 Aug 2021 10-K 15 Dec 2022 2022 FY
Q2 2021 $51,552 -$589,643 -92% 31 May 2021 10-Q 13 Jul 2021 2021 Q3
Q1 2021 $128,825 -$496,687 -79% 28 Feb 2021 10-Q 14 Apr 2021 2021 Q2
Q4 2020 $182,112 -$180,104 -50% 30 Nov 2020 10-Q 13 Jan 2021 2021 Q1
Q3 2020 $202,128 -$46,021 -19% 31 Aug 2020 10-K 10 Dec 2021 2021 FY
Q2 2020 $641,195 +$316,471 +97% 31 May 2020 10-Q 20 Jul 2020 2020 Q3
Q1 2020 $625,512 +$162,784 +35% 29 Feb 2020 10-Q 20 Apr 2020 2020 Q2
Q4 2019 $362,216 -$233,326 -39% 30 Nov 2019 10-Q 21 Jan 2020 2020 Q1
Q3 2019 $248,149 -$609,857 -71% 31 Aug 2019 10-K 15 Dec 2020 2020 FY
Q2 2019 $324,724 +$258,527 +391% 31 May 2019 10-Q 18 Jul 2019 2019 Q3
Q1 2019 $462,728 +$399,362 +630% 28 Feb 2019 10-Q 15 Apr 2019 2019 Q2
Q4 2018 $595,542 +$535,349 +889% 30 Nov 2018 10-Q 18 Jan 2019 2019 Q1
Q3 2018 $858,006 +$857,981 31 Aug 2018 10-K 17 Dec 2019 2019 FY
Q2 2018 $66,197 31 May 2018 10-Q 23 Jul 2018 2018 Q3
Q1 2018 $63,366 28 Feb 2018 10-Q 23 Apr 2018 2018 Q2
Q4 2017 $60,193 30 Nov 2017 10-Q 22 Jan 2018 2018 Q1
Q3 2017 $25* 31 Aug 2017 10-K 14 Dec 2018 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.